top of page
Executive Interview
WhatsApp Image 2021-09-03 at 13.38.53.jpeg
   Executive Interviews   
An Interview with
Pristine Chem

Our first API manufacturing plant established in 2007 & got listed in 2010 in DSE ( Dhaka stock exchange) & CSE ( Chittagong stock exchange) where I hold the Chairman position since 2012 .


Pristine Chem - establish last year with a vision to manufacture world standard bulk solvents & exepinents For life life saving drugs


Pristine Life Science: Formed last year with a vision to manufacture global standard API's ( active pharmaceutical ingredients) for life saving drugs for global & local market

Publish Date: 
12 October 2021
Other Countries

Tell us about your background, and how you came to found your company?

Besides our family business I was exploring to diversify and found Healthcare has huge prospects & potential growth for local & global marlet's and after lot of research,calculating facts & figlures decided to get into API ( active pharmaceuticals ingredient) manufacturing.

What is most important to you and your organization – mission, vision, or core values? Why?

Mission- To become a global standard API ( active pharmacutical ingredient) & bulk pharma solvents manufacturer


Vision - To alleviate human wellbeing as a catalyst in the best possible way though innovation & hard work .


Core values : Innovation, teamwork,trust & respect, responsibility, ethics, customers as priority.

Can you explain briefly how your service(s)/product(s) works?

We are manufacturing API ( active pharmacuetical ingredients) & Pharma grade solvents, excepients . Whis is the raw material of life saving drugs.



Unique agreement by World Trade Organization under TRIPS treaty to export to other LDCs, patent fees exempted until 2033.

Bangladesh is recognized as No. 1 amongst the other LDCs for life- saving drugs with well-established drug manufacturing industry making the country 95% self-sufficient.


Government incentives to grow export sector including

- 20% cash incentive on all export sales until 2026.

- 100% TAX holiday as well as exemption from advance income tax until 2032 With conditions .

- Competitive quality and pricing ability to export to developed countries.



How has the industry been changing in recent years?

The Global Market is worth USD 934.8 billion in 2019 and will reach USD 1.17 trillion in 2025, a CAGR of 6.9% of which API will be a USD 245 Billion Industry at CAGR of 5.4% in 2025.



What makes you different from what’s currently available in the market?

The hole world is heavy depending on China & India for API & other excepients to manufacture life saving drugs . More then 60% are importing from this country but given trips treaty by WTO the won't be able to manufacture patented API's but Bangladesh can as LDC and sell to other LDC countries without paying patent rights fees which is a huge competitive advantage .


What does the future hold for your company?

I'm very confident & hopeful for the future of our company as I see exponential growth in local & global markets.


Given the advantages as LDC country & Bangladesh Goverment policy support for the sector we can & have long way to go .



Supplementary Information

bottom of page